633 related articles for article (PubMed ID: 24461862)
1. Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.
Chan YC; Cheng SW; Ting AC; Cheung GC
J Vasc Surg; 2014 Feb; 59(2):384-91. PubMed ID: 24461862
[TBL] [Abstract][Full Text] [Related]
2. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
Chan YC; Cheng SW; Cheung GC
J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
[TBL] [Abstract][Full Text] [Related]
3. Stenting of femoropopliteal lesions using interwoven nitinol stents.
Brescia AA; Wickers BM; Correa JC; Smeds MR; Jacobs DL
J Vasc Surg; 2015 Jun; 61(6):1472-8. PubMed ID: 25752693
[TBL] [Abstract][Full Text] [Related]
4. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
[TBL] [Abstract][Full Text] [Related]
5. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
[TBL] [Abstract][Full Text] [Related]
6. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
[TBL] [Abstract][Full Text] [Related]
7. A midterm analysis of patients who received femoropopliteal helical interwoven nitinol stents.
Chan YC; Cheng SW; Cheung GC
J Vasc Surg; 2020 Jun; 71(6):2048-2055. PubMed ID: 32081479
[TBL] [Abstract][Full Text] [Related]
8. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.
Montero-Baker M; Ziomek GJ; Leon L; Gonzales A; Dieter RS; Gadd CL; Pacanowski JP
J Vasc Surg; 2016 Oct; 64(4):1002-8. PubMed ID: 27444365
[TBL] [Abstract][Full Text] [Related]
9. Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
Teymen B; Akturk S; Akturk U; Tdjani M
Vascular; 2018 Feb; 26(1):54-61. PubMed ID: 28708023
[TBL] [Abstract][Full Text] [Related]
10. SUMMIT registry: one-year outcomes after implantation of the EPIC self-expanding nitinol stent in the femoropopliteal segment.
Werner M; Piorkowski M; Thieme M; Nanning T; Beschorner U; Rastan A; Zeller T; Scheinert D
J Endovasc Ther; 2013 Dec; 20(6):759-66. PubMed ID: 24325691
[TBL] [Abstract][Full Text] [Related]
11. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
[TBL] [Abstract][Full Text] [Related]
12. Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions.
Bosiers M; Deloose K; Callaert J; Moreels N; Keirse K; Verbist J; Peeters P
J Vasc Surg; 2011 Oct; 54(4):1042-50. PubMed ID: 21636239
[TBL] [Abstract][Full Text] [Related]
13. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry.
Scheinert D; Werner M; Scheinert S; Paetzold A; Banning-Eichenseer U; Piorkowski M; Ulrich M; Bausback Y; Bräunlich S; Schmidt A
JACC Cardiovasc Interv; 2013 Jan; 6(1):65-71. PubMed ID: 23347863
[TBL] [Abstract][Full Text] [Related]
14. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: Midterm results.
Dumantepe M; Seren M; Fazlıogullari O; Ayoglu U; Teymen B
Vascular; 2021 Oct; 29(5):711-719. PubMed ID: 25687718
[TBL] [Abstract][Full Text] [Related]
15. SUPERA interwoven nitinol Stent Outcomes in Above-Knee IntErventions (SAKE) study.
George JC; Rosen ES; Nachtigall J; VanHise A; Kovach R
J Vasc Interv Radiol; 2014 Jun; 25(6):954-61. PubMed ID: 24768325
[TBL] [Abstract][Full Text] [Related]
16. A Real-World Experience With the Supera Interwoven Nitinol Stent in Femoropopliteal Arteries: Midterm Patency Results and Failure Analysis.
Myint M; Schouten O; Bourke V; Thomas SD; Lennox AF; Varcoe RL
J Endovasc Ther; 2016 Jun; 23(3):433-41. PubMed ID: 27004494
[TBL] [Abstract][Full Text] [Related]
17. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
[TBL] [Abstract][Full Text] [Related]
18. Three year results of endovascular therapy with a new generation nitinol stent for femoro-popliteal artery lesions - a single-center outcome analysis of a subcohort of MISAGO 2 study.
Kralj I; Boos I; Müller-Bühl U
Vasa; 2013 Sep; 42(5):340-9. PubMed ID: 23989069
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery.
León LR; Dieter RS; Gadd CL; Ranellone E; Mills JL; Montero-Baker MF; Gruessner AC; Pacanowski JP
J Vasc Surg; 2013 Apr; 57(4):1014-22. PubMed ID: 23535039
[TBL] [Abstract][Full Text] [Related]
20. The use of the GORE® TIGRIS® Vascular Stent with dual component design in the superficial femoral and popliteal arteries at 6 months.
Piorkowski M; Freitas B; Schmidt A; Bräunlich S; Ulrich M; Schuster J; Bausback Y; Werner M; Scheinert D
J Cardiovasc Surg (Torino); 2013 Aug; 54(4):447-53. PubMed ID: 24013533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
